|
|
Volumn 355, Issue 6, 2006, Pages 627-
|
|
Imatinib and altered bone and mineral metabolism [8]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
25 HYDROXYVITAMIN D;
ALBUMIN;
CALCIUM;
IMATINIB;
PARATHYROID HORMONE;
PHOSPHATE;
PLATELET DERIVED GROWTH FACTOR;
25-HYDROXYVITAMIN D;
BIOLOGICAL MARKER;
DRUG DERIVATIVE;
OSTEOCALCIN;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
VITAMIN D;
ALBUMIN BLOOD LEVEL;
BONE TURNOVER;
CALCIUM BLOOD LEVEL;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
DRUG INDUCED DISEASE;
HUMAN;
HYPOPHOSPHATEMIA;
LETTER;
OSTEOMALACIA;
PHOSPHATE BLOOD LEVEL;
PRIORITY JOURNAL;
BLOOD;
BLOOD SAMPLING;
BONE;
CHEMICALLY INDUCED DISORDER;
METABOLISM;
NOTE;
STANDARD;
BIOLOGICAL MARKERS;
BLOOD SPECIMEN COLLECTION;
BONE AND BONES;
CALCIUM;
HUMANS;
HYPOPHOSPHATEMIA;
OSTEOCALCIN;
PARATHYROID HORMONE;
PHOSPHATES;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
VITAMIN D;
|
|
EID: 33746903194
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc061565 Document Type: Letter |
|
Times cited : (17)
|
|
References (3)
|
